MTCO3P38

Across TCGA pan-cancer cohorts, MTCO3P38 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MTCO3P38 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MTCO3P38 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO3P38 expression acts as an unfavorable survival marker, although some lineages such as LUSC and BLCA show a favorable association.

UCEC, LUSC, and BRCA are the cancer types where MTCO3P38 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	III,IV	0.090	0.609	<.001	108	view →
LUSC	DFS	Tertile	All	0.887	0.722	.001	72	view →
BRCA	OS	Tertile	All	0.938	0.964	.021	54	view →
ACC	OS	Tertile	III,IV	0.241	0.613	.011	36	view →
LUAD	DFS	Tertile	II,III,IV	0.529	0.692	.023	27	view →
UVM	OS	Tertile	All	0.313	0.761	<.001	18	view →
GBM	DFS	Tertile	All	0.149	0.314	.017	18	view →
BLCA	OS	Tertile	III,IV	0.780	0.232	.026	18	view →
UCS	OS	Tertile	All	0.201	0.583	.035	18	view →
ESCA	DFS	Tertile	All	0.243	0.913	.004	15	view →
LAML	DFS	Quartile	All	0.599	0.251	.015	10	view →
THCA	DFS	Tertile	III,IV	0.624	0.878	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MTCO3P38–UCEC (OS)

Open the UCEC breakdown →